DSM Concludes Acquisition of Outstanding Shares in DSM-AGI
AMSTERDAM - Royal DSM has concluded the acquisition of the outstanding 49% of shares in its DSM-AGI joint venture, gaining sole ownership of the Taiwan-based supplier of UV-curable resins and other specialty chemicals.
DSM issued a public tender offer to purchase the remaining shares of DSM-AGI Corp. via one of its affiliates on March 3, 2017. This process has now been completed, and the company has been delisted from the Taipei stock exchange.